10x Genomics (NASDAQ:TXG) Trading Down 4.8% Following Analyst Downgrade
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) dropped 4.8% during mid-day trading on Monday after Morgan Stanley lowered their price target on the stock from $26.00 to $18.00. Morgan Stanley currently has an overweight rating on the stock. 10x Genomics traded as low as $8.88 and last traded at $8.94. Approximately 437,420 shares traded […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) dropped 4.8% during mid-day trading on Monday after Morgan Stanley lowered their price target on the stock from $26.00 to $18.00. Morgan Stanley currently has an overweight rating on the stock. 10x Genomics traded as low as $8.88 and last traded at $8.94. Approximately 437,420 shares traded […]
